Toggle light / dark theme

In Episode 6 of the Lifespan podcast, Dr. David Sinclair and co-host Matthew LaPlante discuss cosmetic aging and how to improve skin, nails, and hair. They talk about why superficial aging occurs and how external signs of aging are often a reflection of biological age. The latest science behind various beautifying therapies is highlighted, including newer interventions like low-level laser therapy and platelet-rich plasma injections. #DavidSinclair #Longevity #SkinCare T.

In the final episode of this season, Dr. David Sinclair and Matthew LaPlante focus on current and near-future technologies relevant to health and aging. In addition to discussing the utility of wearable sensors and biological age measurements, they highlight innovative research aimed at reversing biological age. The societal effects of therapies that successfully extend healthspan and/or lifespan are also considered. #DavidSinclair #Longevity #Aging

In this episode, Dr. David Sinclair and co-host Matthew LaPlante discuss why we age. In doing so, they discuss organisms that have extreme longevity, the genes that control aging (mTOR, AMPK, Sirtuins), the role of sirtuin proteins as epigenetic regulators of aging, the process of “ex-differentiation” in which cells begin to lose their identity, and how all of this makes up the “Information Theory of Aging”, and the difference between “biological age” and “chronological age” and how we can measure biological age through DNA methylation clocks. #Aging #DavidSinclair #Longevity

In this week’s episode, Dr. David Sinclair and co-host Matthew LaPlante zero in on drugs and supplements that have been reported to combat aspects of aging. They share the latest experimental and clinical data for NAD boosters (these being NR, NMN, NAD IV drips and shots), resveratrol, fisetin, quercetin, rapamycin, spermidine, metformin, and berberine.

Earlier this week, Google launched its Gemini AI platform that ‘wowed’ the tech world. A video posted on YouTube showcased the new AI model’s capabilities to process and reason with text, images, audio, video, and code. However, it has since come to light that Google staged the hands-on video demonstration of Gemini AI.

Bloomberg reports that Google modified interactions with Gemini AI to create the demonstration video. The video is titled “Hands-on with Gemini: Interacting with Multimodal AI.”

Google admitted in the video’s description: “For the purposes of this demo, latency has been reduced, and Gemini outputs have been shortened for brevity.” In other words, the model’s response time takes much longer than the video showed.

LONDON (AP) — European Union negotiators clinched a deal Friday on the world’s first comprehensive artificial intelligence rules, paving the way for legal oversight of technology used in popular generative AI services like ChatGPT that has promised to transform everyday life and spurred warnings of existential dangers to humanity.

Negotiators from the European Parliament and the bloc’s 27 member countries overcame big differences on controversial points including generative AI and police use of facial recognition surveillance to sign a tentative political agreement for the Artificial Intelligence Act.

“Deal!” tweeted European Commissioner Thierry Breton, just before midnight. “The EU becomes the very first continent to set clear rules for the use of AI.”

The results of the clinical trial were published Dec. 4 in Nature Medicine.

More than 5 million Americans live with the lasting effects of moderate to severe traumatic brain injury — difficulty focusing, remembering and making decisions. Though many recover enough to live independently, their impairments prevent them from returning to school or work and from resuming their social lives.